TY - JOUR
T1 - Spatial location of local recurrences after mastectomy
T2 - a systematic review
AU - Kaidar-Person, Orit
AU - Poortmans, Philip
AU - Offersen, Birgitte Vrou
AU - Siesling, Sabine
AU - Sklair-Levy, Miri
AU - Meattini, Icro
AU - de Ruysscher, Dirk
AU - Kuehn, Thorsten
AU - Boersma, Liesbeth J.
N1 - Funding Information:
We thank Alina Markinzon, a medical librarian from Sheba Tel H’ashomer, for her assistance. All figures and illustrations are original. Illustrations were done by Alon Person, via Adobe Illustrator cc 2019. The authors thank Alon Person for his contribution.
Publisher Copyright:
© 2020, Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2020/9
Y1 - 2020/9
N2 - Purpose: We performed a systematic review to document the spatial location of local recurrences (LR) after mastectomy. Methods: A PubMed search was conducted in August 2019 for the following terms: breast [Title/Abstract] AND cancer [Title/Abstract] AND recurrence [Title/Abstract] AND mastectomy [Title/Abstract]. The search was filtered for English language. Exclusion criteria included studies that did not specify the LR location or studies reporting LR associated with inflammatory breast cancer, or other breast cancers such as phyllodes tumours, lymphoma or associated with sarcoma/angiosarcoma. Results: A total of 3922 titles were identified, of which 21 publications were eligible for inclusion in the final analysis. A total of 6901 mastectomy patients were included (range 25–1694). The mean LR proportion was 3.5%. Among the total of 351 LR lesions, 81.8% were in the subcutaneous tissue and the skin, while 16% were pectoral muscle recurrences. Conclusion: Local recurrences are mostly located within the subcutaneous tissue and the skin, assumed to result from unrecognized/subclinical tumour foci left behind after mastectomy, surgical implantation of tumour cells in the wound/scar and/or tumour emboli within the subcutaneous lymphatics. Pectoral muscle recurrences are less frequent and may be attributed to residual disease along the posterior surgical margin and/or lymphatic involvement.
AB - Purpose: We performed a systematic review to document the spatial location of local recurrences (LR) after mastectomy. Methods: A PubMed search was conducted in August 2019 for the following terms: breast [Title/Abstract] AND cancer [Title/Abstract] AND recurrence [Title/Abstract] AND mastectomy [Title/Abstract]. The search was filtered for English language. Exclusion criteria included studies that did not specify the LR location or studies reporting LR associated with inflammatory breast cancer, or other breast cancers such as phyllodes tumours, lymphoma or associated with sarcoma/angiosarcoma. Results: A total of 3922 titles were identified, of which 21 publications were eligible for inclusion in the final analysis. A total of 6901 mastectomy patients were included (range 25–1694). The mean LR proportion was 3.5%. Among the total of 351 LR lesions, 81.8% were in the subcutaneous tissue and the skin, while 16% were pectoral muscle recurrences. Conclusion: Local recurrences are mostly located within the subcutaneous tissue and the skin, assumed to result from unrecognized/subclinical tumour foci left behind after mastectomy, surgical implantation of tumour cells in the wound/scar and/or tumour emboli within the subcutaneous lymphatics. Pectoral muscle recurrences are less frequent and may be attributed to residual disease along the posterior surgical margin and/or lymphatic involvement.
KW - Breast cancer
KW - Mastectomy
KW - Breast reconstruction
KW - Nipple sparing
KW - Skin sparing
KW - Local recurrence
KW - SKIN-SPARING MASTECTOMY
KW - ESTRO CONSENSUS GUIDELINE
KW - BREAST-CONSERVING THERAPY
KW - NIPPLE-AREOLA COMPLEX
KW - POSTMASTECTOMY RADIATION-THERAPY
KW - TARGET VOLUME DELINEATION
KW - CHEST-WALL RECURRENCES
KW - IMMEDIATE RECONSTRUCTION
KW - LOCOREGIONAL RECURRENCE
KW - CANCER RECURRENCE
U2 - 10.1007/s10549-020-05774-4
DO - 10.1007/s10549-020-05774-4
M3 - (Systematic) Review article
C2 - 32661665
SN - 0167-6806
VL - 183
SP - 263
EP - 273
JO - Breast Cancer Research and Treatment
JF - Breast Cancer Research and Treatment
IS - 2
ER -